Paula Rodriguez-Marquez

4PUBLICATIONS
39CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 05, 2026
IRF2 is an essential transcription factor with pathogenic and prognostic impact in multiple myeloma.

|Aug 29, 2025
Genetic Engineering in CAR T Cells for Solid Tumors: Current State, Barriers and Future Developments.

Rodrigo A Redondo-Frutos, Pedro Justicia-Lirio, Carmen Barbero-Jimenez

|Jul 26, 2024
Molecular mechanisms promoting long-term cytopenia after BCMA CAR-T therapy in multiple myeloma.

Maria Luisa Palacios-Berraquero, Paula Rodriguez-Marquez, Maria Erendira Calleja-Cervantes

|Sep 30, 2022
CAR density influences antitumoral efficacy of BCMA CAR T cells and correlates with clinical outcome.

Paula Rodriguez-Marquez, Maria E Calleja-Cervantes, Guillermo Serrano

Pageof 1

Frequent Collaborators

3 joint publications

Juan Roberto Rodriguez-Madoz

3 joint publications

Felipe Prosper

3 joint publications

Paula Rodriguez-Otero

2 joint publications

Maria Erendira Calleja-Cervantes